Verona, Italy

Alessandra Pasquarello

USPTO Granted Patents = 10 

 

Average Co-Inventor Count = 5.2

ph-index = 3

Forward Citations = 41(Granted Patents)


Company Filing History:


Years Active: 2002-2012

Loading Chart...
Loading Chart...
10 patents (USPTO):Explore Patents

Title: The Innovative Mind of Alessandra Pasquarello: A Journey Through Patents and Discoveries

Introduction: Alessandra Pasquarello, an accomplished inventor based in Verona, Italy, has made significant contributions to the field of pharmaceuticals with her innovative compounds. With a remarkable portfolio consisting of 10 patents, she has emerged as a key figure in the development of treatments for complex health issues.

Latest Patents: Among her latest inventions are groundbreaking azabicyclo compounds, specifically designed to modulate dopamine D receptors. These innovative compounds hold the potential to address various medical challenges, including drug dependency, as well as serving as antipsychotic agents and treatments for obsessive-compulsive spectrum disorders and premature ejaculation.

Career Highlights: Throughout her career, Alessandra has worked for notable companies in the pharmaceutical industry, including Glaxo Group Limited and Glaxo Wellcome Spa. Her experience with these leading organizations has equipped her with the knowledge and expertise necessary to develop her cutting-edge inventions.

Collaborations: Alessandra has had the privilege of collaborating with esteemed colleagues such as Fabrizio Micheli and Romano Di Fabio. These partnerships have fostered a collaborative environment for innovation, contributing to her successful patent development.

Conclusion: Alessandra Pasquarello's work exemplifies the synergy between inventive prowess and scientific research. Her dedication to finding effective solutions for pressing medical issues underscores her significant impact on the pharmaceutical field. With each patent, she continues to shape the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…